Case number 2018-2414
Amgen Inc. v. Amneal Pharmaceuticals LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | AMGEN INC. v. AMNEAL PHARMACEUTICALS LLC [OPINION - PRECEDENTIAL] [precedential] (0) |
| Apr 22, 2020 | 132 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [689152] [18-2414, 19-1086] [JAB] [Entered: 04/22/2020 12:57 PM] (1) |
| Apr 15, 2020 | 131 | ORDER filed denying [119] petition for panel rehearing filed by Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals of New York LLC, denying [120] petition for panel rehearing, for en banc rehearing filed by Amgen Inc. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [687042] [JAB] [Entered: 04/15/2020 09:58 AM] (2) |
| Apr 14, 2020 | 130 | ORDER filed denying [127] motion to file a response/reply filed by Amgen Inc. By: Per Curiam. Service as of this date by the Clerk of Court. [686685] [JAB] [Entered: 04/14/2020 10:01 AM] (2) |
| Apr 10, 2020 | 128 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Amgen Inc., Motion for leave to file reply to petition for rehearing [126], is not in compliance with the rules of this court (see attached). Service as of this date by the Clerk of Court. [685814] [JAB] [Entered: 04/10/2020 08:31 AM] (1) |
| Apr 10, 2020 | 129 | RESPONSE of Appellee Piramal Healthcare UK Limited to the motion to file a response/reply [127] filed by Appellant Amgen Inc.. Service: 04/10/2020 by email. [686167] [18-2414] [Aaron Barkoff] [Entered: 04/10/2020 09:42 PM] (11) |
| Apr 9, 2020 | 126 | MOTION of Appellant Amgen Inc. for leave to file a response/reply to Doc. No. [125], Doc. No. [124] [Consent: partial consent]. Service: 04/09/2020 by email. [685790] [18-2414] This document is non-compliant. See Doc. No. [128]. [Constantine Trela] [Entered: 04/09/2020 09:00 PM] (19) |
| Apr 9, 2020 | 127 | MOTION of Appellant Amgen Inc. for leave to file a response/reply to Doc. No. [125], Doc. No. [124] [Consent: partial consent]. Service: 04/09/2020 by email. [685793] [18-2414] [Bradford Badke] [Entered: 04/09/2020 09:37 PM] (19) |
| Mar 30, 2020 | 124 | RESPONSE of Cross-Appellants Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc. to the petition [120] filed by Appellant Amgen Inc., petition [120] filed by Appellant Amgen Inc.. Service: 03/30/2020 by email. [682852] [18-2414] [Steven Maddox] [Entered: 03/30/2020 04:41 PM] (6) |
| Mar 30, 2020 | 125 | RESPONSE of Appellee Piramal Healthcare UK Limited to the petition [120] filed by Appellant Amgen Inc., petition [120] filed by Appellant Amgen Inc.. Service: 03/30/2020 by email. [682900] [18-2414] [Aaron Barkoff] [Entered: 03/30/2020 06:39 PM] (21) |
| Mar 16, 2020 | 123 | The court invites responses from (1) Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals of New York LLC, (2) Piramal Healthcare UK Limited, and (3) Cross-Appellants Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc. to the combined petition for rehearing [120] filed by Appellant in 18-2414. [679265] [MJL] [Entered: 03/16/2020 05:21 PM] (2) |
| Feb 14, 2020 | 121 | 18 paper copies of the petition for panel rehearing [120], petition for en banc rehearing [120] received from Appellant Amgen Inc. [671386] [JAB] [Entered: 02/14/2020 11:24 AM] (0) |
| Feb 14, 2020 | 122 | 3 paper copies of the petition for panel rehearing [119] received from Appellees Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals of New York LLC. [671541] [JAB] [Entered: 02/14/2020 01:42 PM] (0) |
| Feb 13, 2020 | 119 | Petition for panel rehearing filed by Appellees Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals of New York LLC. Service: 02/13/2020 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 02/18/2020 [671212] [18-2414] [Jacob Holdreith] [Entered: 02/13/2020 06:18 PM] (52) |
| Feb 13, 2020 | 120 | Petition for panel rehearing, for en banc rehearing filed by Appellant Amgen Inc.. Service: 02/13/2020 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 02/18/2020 [671240] [18-2414] [Bradford Badke] [Entered: 02/13/2020 08:45 PM] (52) |
| Jan 31, 2020 | 118 | ORDER filed granting motion to extend time to file petition for rehearing/en banc [117] filed by Appellant Amgen Inc. Petition for Rehearing due on or before 02/13/2020. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [667652] [JAB] [Entered: 01/31/2020 01:19 PM] (2) |
| Jan 30, 2020 | 117 | MOTION of Appellant Amgen Inc. to extend the time to file a Petiton for Panel Rehearing until 02/13/2020 [Consent: unopposed]. Service: 01/30/2020 by email. [667473] [18-2414] [Bradford Badke] [Entered: 01/30/2020 07:14 PM] (8) |
| Jan 7, 2020 | 115 | OPINION filed for the court by Newman, Circuit Judge; Lourie, Circuit Judge and Taranto, Circuit Judge. Precedential Opinion. [661170] [18-2414, 19-1086] [MJL] [Entered: 01/07/2020 09:41 AM] (28) |
| Jan 7, 2020 | 116 | JUDGMENT. AFFIRMED-IN-PART, REVERSED-IN-PART, VACATED-IN-PART, AND REMANDED. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [661172] [18-2414, 19-1086] [MJL] [Entered: 01/07/2020 09:43 AM] (2) |
| Oct 1, 2019 | 114 | Submitted after ORAL ARGUMENT by Bradford J. Badke for Amgen Inc., Aaron Barkoff for Piramal Healthcare UK Limited, Mr. Jacob M. Holdreith for Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC, Piramal Healthcare UK Limited, Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc. and Mr. Steven Arthur Maddox for Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc. Panel: Judge: Newman , Judge: Lourie , Judge: Taranto. [639324] [JCP] [Entered: 10/01/2019 10:56 AM] (0) |
| Sep 23, 2019 | 113 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [110], ERROR: The firm information listed on the Entry of Appearance for Alicia A. Russo does not match does not match the information listed on the attorney's user account. CORRECTION: Please promptly update to ensure the information with the PACER Service Center matches the entry of appearance. [637258] [JAB] [Entered: 09/23/2019 07:58 AM] (0) |
| Sep 20, 2019 | 110 | Amended Entry of appearance for Alicia A. Russo as of counsel for Appellant Amgen Inc.. Service: 09/20/2019 by email. [637085] [18-2414] [Bradford Badke] [Entered: 09/20/2019 02:42 PM] (2) |
| Sep 20, 2019 | 111 | Amended Entry of appearance for John D. Murnane as of counsel for Appellant Amgen Inc.. Service: 09/20/2019 by email. [637087] [18-2414] [Bradford Badke] [Entered: 09/20/2019 02:43 PM] (2) |
| Sep 20, 2019 | 112 | Amended Entry of appearance for Joshua I. Rothman as of counsel for Appellant Amgen Inc.. Service: 09/20/2019 by email. [637089] [18-2414] [Bradford Badke] [Entered: 09/20/2019 02:43 PM] (2) |
| Sep 13, 2019 | 107 | Response to notice of oral argument from the Appellees Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC and Piramal Healthcare UK Limited and Cross-Appellants Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc. [635365] [18-2414]--[Edited 09/13/2019 by JAB to correct filers] [Jacob Holdreith] [Entered: 09/13/2019 12:39 PM] (3) |
| Sep 13, 2019 | 108 | Response to notice of oral argument from the Appellee Piramal Healthcare UK Limited. [635550] [18-2414] [Aaron Barkoff] [Entered: 09/13/2019 04:59 PM] (3) |
| Sep 13, 2019 | 109 | Response to notice of oral argument from the Cross-Appellants Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc.. [635560] [18-2414] [Steven Maddox] [Entered: 09/13/2019 06:54 PM] (3) |
| Sep 10, 2019 | 106 | Response to notice of oral argument from the Appellant Amgen Inc.. [634488] [18-2414] [Bradford Badke] [Entered: 09/10/2019 05:13 PM] (3) |
| Aug 23, 2019 | 105 | RESPONSE of Appellee Piramal Healthcare UK Limited to the supplemental authority [103] filed by Appellant Amgen Inc.. Service: 08/23/2019 by email. [630668] [18-2414] [Aaron Barkoff] [Entered: 08/23/2019 02:28 PM] (3) |
| Aug 21, 2019 | 104 | NOTICE OF ORAL ARGUMENT. Panel: 1910H. Case scheduled October 1, 2019 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 201. Response to Notice of Oral Argument due: 09/16/2019. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [629886] [JAB] [Entered: 08/21/2019 01:25 PM] (2) |
| Aug 20, 2019 | 103 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellant Amgen Inc.. Service: 08/20/2019 by email. [629539] [18-2414] [Bradford Badke] [Entered: 08/20/2019 11:23 AM] (31) |
| May 1, 2019 | 98 | Notice from Appellant Amgen Inc. regarding conflicts with oral argument. Service: 05/01/2019 by email. [604240] [18-2414] [Bradford Badke] [Entered: 05/01/2019 09:18 AM] (3) |
| May 1, 2019 | 99 | The following conflict dates submitted by Attorney Bradford J. Badke for Appellant Amgen Inc. have been accepted by the court: 07/11/2019, 07/12/2019. [604268] [PBC] [Entered: 05/01/2019 10:02 AM] (0) |
| May 1, 2019 | 100 | Notice from Appellee Piramal Healthcare UK Limited regarding conflicts with oral argument. None. Service: 05/01/2019 by email. [604341] [18-2414] [Aaron Barkoff] [Entered: 05/01/2019 12:15 PM] (0) |
| May 1, 2019 | 101 | Notice from Cross-Appellants Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc. regarding conflicts with oral argument. Service: 05/01/2019 by email. [604400] [18-2414] [Steven Maddox] [Entered: 05/01/2019 01:59 PM] (2) |
| May 1, 2019 | 102 | The following conflict dates submitted by Attorney Steven Arthur Maddox for Cross-Appellants Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc. have been accepted by the court: 09/03/2019, 09/04/2019, 09/05/2019, 09/06/2019, 11/04/2019, 11/05/2019, 11/06/2019, 11/07/2019, 11/08/2019. [604414] [JAB] [Entered: 05/01/2019 02:46 PM] (0) |
| Apr 29, 2019 | 96 | Notice from Appellees Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals of New York LLC regarding conflicts with oral argument. Service: 04/29/2019 by email. [603524] [18-2414] [Jacob Holdreith] [Entered: 04/29/2019 10:46 AM] (2) |
| Apr 29, 2019 | 97 | The following conflict dates submitted by Attorney Jacob M. Holdreith for Appellees Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals of New York LLC have been accepted by the court: 07/10/2019, 08/07/2019, 08/08/2019, 08/09/2019. [603563] [JAB] [Entered: 04/29/2019 11:36 AM] (0) |
| Apr 26, 2019 | 95 | 6 paper copies of the Opening Response Brief [67] received from Appellees Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC and Piramal Healthcare UK Limited. [603147] [CJF] [Entered: 04/26/2019 10:21 AM] (0) |
| Apr 25, 2019 | 90 | 6 paper copies of the Corrected Confidential Opening Response Brief [70] received from Cross-Appellants Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc.. [602908] [CJF] [Entered: 04/25/2019 12:04 PM] (0) |
| Apr 25, 2019 | 91 | 6 paper copies of the Reply Brief [78] received from Cross-Appellants Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc.. [602958] [CJF] [Entered: 04/25/2019 02:33 PM] (0) |
| Apr 25, 2019 | 92 | 6 paper copies of the Corrected Confidential Opening Brief [55] received from Appellant Amgen Inc.. [602994] [CJF] [Entered: 04/25/2019 03:19 PM] (0) |
| Apr 25, 2019 | 93 | 6 paper copies of the Confidential Response and Reply Brief [76] received from Appellant Amgen Inc.. [602995] [CJF] [Entered: 04/25/2019 03:21 PM] (0) |
| Apr 25, 2019 | 94 | 6 paper copies of the Corrected Confidential Joint Appendix Brief (Vol. I - III) [87] received from Appellant Amgen Inc., Appellees Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC, Piramal Healthcare UK Limited and Cross-Appellants Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc.. [602997] [CJF] [Entered: 04/25/2019 03:25 PM] (0) |
| Apr 24, 2019 | 88 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [602617] [JAL] [Entered: 04/24/2019 01:41 PM] (0) |
| Apr 24, 2019 | 89 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The notice of conflict with oral argument is due on or before 05/01/2019. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [602618] [JAL] [Entered: 04/24/2019 01:41 PM] (1) |
| Apr 18, 2019 | 86 | Notice of Correction to the confidential Brief Doc No. [83] for Appellant Amgen Inc.. Service: 04/18/2019 by email. [601345] [18-2414] [Bradford Badke] [Entered: 04/18/2019 02:51 PM] (3) |
| Apr 18, 2019 | 87 | MODIFIED ENTRY: CORRECTED CONFIDENTIAL JOINT APPENDIX FILED for Appellant Amgen Inc., Appellees Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC, Piramal Healthcare UK Limited, and Cross-Appellants Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc. Number of Pages: 1592. Service: 04/18/2019 by email. [601351]--[Edited 04/18/2019 by JAL - Compliance review complete] [Bradford Badke] [Entered: 04/18/2019 03:06 PM] (0) |
| Apr 17, 2019 | 79 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Piramal Healthcare UK Limited. Service: 04/17/2019 by email. [601029] [18-2414] [Aaron Barkoff] [Entered: 04/17/2019 02:46 PM] (3) |
| Apr 17, 2019 | 80 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Cross-Appellants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.. Service: 04/17/2019 by email. [601040] [18-2414] [Steven Maddox] [Entered: 04/17/2019 03:13 PM] (3) |
| Apr 17, 2019 | 81 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals of New York LLC. Service: 04/17/2019 by email. [601051] [18-2414] [Brenda Joly] [Entered: 04/17/2019 03:48 PM] (2) |
| Apr 17, 2019 | 82 | MODIFIED ENTRY: JOINT APPENDIX FILED for Appellant Amgen Inc., Appellees Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC, Piramal Healthcare UK Limited, and Cross-Appellants Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc. Number of Pages: 1283. Service: 04/17/2019 by email. [601109] --[Edited 04/18/2019 by JAL - Compliance review complete] [Bradford Badke] [Entered: 04/17/2019 08:29 PM] (1283) |
| Apr 17, 2019 | 83 | FILED from Appellant Amgen Inc., Appellees Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC, Piramal Healthcare UK Limited and Cross-Appellants Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc.. Title: CONFIDENTIAL JOINT APPENDIX. Service: 04/17/2019 by email. [601114] [18-2414] This brief has been corrected. See Doc No.[87]--[Edited 04/18/2019 by JAL to reflect filing of corrected brief] [Bradford Badke] [Entered: 04/17/2019 09:07 PM] (0) |
| Apr 17, 2019 | 84 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Amgen Inc.. Service: 04/17/2019 by email. [601116] [18-2414] [Bradford Badke] [Entered: 04/17/2019 09:19 PM] (3) |
| Apr 17, 2019 | 85 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Amgen Inc., Appellees Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC, Piramal Healthcare UK Limited and Cross-Appellants Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc.. Service: 04/17/2019 by email. [601117] [18-2414] [Bradford Badke] [Entered: 04/17/2019 09:25 PM] (4) |
| Apr 10, 2019 | 78 | MODIFIED ENTRY: REPLY BRIEF FILED for Cross-Appellants Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc. Number of Pages: 19. Service: 04/10/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [599063] --[Edited 04/10/2019 by JAL - Compliance review complete] [Steven Maddox] [Entered: 04/10/2019 03:31 PM] (26) |
| Mar 21, 2019 | 77 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:Opening Brief Docket No. [54], Opening Brief Docket No. [55], Reply Brief Docket No. [75], Reply Brief Docket No. [76], ERROR: The court notes that the caption used on the opening and reply briefs for Appellant Amgen Inc. contain "et al." CORRECTION: Please list the full caption on the covers of the briefs; the use of "et al" is not allowed. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [594397] [JAL] [Entered: 03/21/2019 10:44 AM] (0) |
| Mar 20, 2019 | 75 | MODIFIED ENTRY: RESPONSE AND REPLY BRIEF FILED for Appellant Amgen Inc. Number of Pages: 42. Service: 03/20/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [594326] --[Edited 03/21/2019 by JAL - Compliance review complete] [Bradford Badke] [Entered: 03/20/2019 06:53 PM] (53) |
| Mar 20, 2019 | 76 | MODIFIED ENTRY: CONFIDENTIAL RESPONSE AND REPLY BRIEF FILED for Appellant Amgen Inc. Number of Pages: 42. Service: 03/20/2019 by email. [594327]--[Edited 03/21/2019 by JAL - Compliance review complete] [Bradford Badke] [Entered: 03/20/2019 06:55 PM] (0) |
| Mar 12, 2019 | 74 | Notice from Appellant Amgen Inc. Status of pending motion for an indicative ruling. Service: 03/12/2019 by email. [592359] [18-2414] [Ryan Morris] [Entered: 03/12/2019 06:16 PM] (4) |
| Feb 13, 2019 | 72 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [69], ERROR: The contact information listed on the entry of appearance for William Hare [69] does not match the information in the attorney's user account. CORRECTION: Please update as needed to ensure that the contact information on the entry of appearance and the user account matches. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [585516] [JAL] [Entered: 02/13/2019 09:58 AM] (0) |
| Feb 13, 2019 | 73 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:Opening Response Brief Docket No. [70], Opening Response Brief Docket No. [71], ERROR: The contact information for Renita Rathinam on the covers of the briefs do not match the information in the attorney's user account. CORRECTION: Please update as needed to ensure that the information matches. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [585627] [JAL] [Entered: 02/13/2019 01:51 PM] (0) |
| Feb 12, 2019 | 69 | Entry of appearance for William Hare as of counsel for Cross-Appellants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.. Service: 02/12/2019 by email. [585212] [18-2414] [Steven Maddox] [Entered: 02/12/2019 12:49 PM] (2) |
| Feb 12, 2019 | 70 | MODIFIED ENTRY: CORRECTED CONFIDENTIAL RESPONSE BRIEF FILED for Cross-Appellants Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc. Number of Pages: 53. Service: 02/12/2019 by email. [585266]--[Edited 02/13/2019 by JAL - Compliance review complete] [Steven Maddox] [Entered: 02/12/2019 02:07 PM] (0) |
| Feb 12, 2019 | 71 | MODIFIED ENTRY: CORRECTED RESPONSE BRIEF FILED for Cross-Appellants Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc. Number of Pages: 53. Service: 02/12/2019 by email. See Fed. Cir. R. 31. [585268] --[Edited 02/13/2019 by JAL - Compliance review complete] [Steven Maddox] [Entered: 02/12/2019 02:12 PM] (71) |
| Feb 11, 2019 | 68 | NOTICE OF NON-COMPLIANCE: The submissions of Cross-Appellants Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc., Confidential Response Brief; Response Brief [65], [66], are not in compliance with the rules of this court (see attached). Compliant documents due on 02/19/2019. Service as of this date by the Clerk of Court.[584973] [JAL] [Entered: 02/11/2019 04:23 PM] (2) |
| Feb 8, 2019 | 65 | FILED from Cross-Appellants Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc.. Title: CONFIDENTIAL RESPONSE BRIEF. Service: 02/08/2019 by email. [584501] [18-2414] This document is non-compliant. See Doc No.[68] [Steven Maddox] [Entered: 02/08/2019 01:46 PM] (0) |
| Feb 8, 2019 | 66 | FILED from Cross-Appellants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.. Title: RESPONSE BRIEF. Service: 02/08/2019 by email. [584502] [18-2414] This document is non-compliant. See Doc No.[68] [Steven Maddox] [Entered: 02/08/2019 01:49 PM] (71) |
| Feb 8, 2019 | 67 | MODIFIED ENTRY: RESPONSE BRIEF FILED for Appellees Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC, and Piramal Healthcare UK Limited. Number of Pages: 58. Service: 02/08/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [584559] --[Edited 02/12/2019 by JAL - Compliance review complete] [Jacob Holdreith] [Entered: 02/08/2019 03:39 PM] (72) |
| Feb 1, 2019 | 64 | ORDER filed. The motion [63] is granted to the extent that the appeal from No. 1:16-cv-00855-MSG between Amgen Inc., and Watson Laboratories and Actavis Pharma is deconsolidated from Appeal Nos. 2018-2414 and 2019-1086. The new appeal from No. 1:16-cv-00855-MSG will be opened under a new appeal number, and all proceedings in that new appeal will be stayed. The stay imposed by the court’s January 11, 2019 order (ECF No. 61) is lifted as to 2018-2414 and 2019-1086. Service: 02/01/2019 by clerk. [582816] [NL] [Entered: 02/01/2019 02:04 PM] (3) |
| Jan 15, 2019 | 62 | Amended Certificate of Interest for the Cross-Appellants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.. Service: 01/15/2019 by email. [578169] [18-2414] [Steven Maddox] [Entered: 01/15/2019 03:13 PM] (3) |
| Jan 15, 2019 | 63 | MOTION of Appellees Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC, Piramal Healthcare UK Limited and Cross-Appellants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd. to clarify [61], to deconsolidate appeals [Consent: unopposed]. Service: 01/15/2019 by email. [578322] [18-2414] [Aaron Barkoff] [Entered: 01/15/2019 04:49 PM] (9) |
| Jan 11, 2019 | 61 | ORDER filed. The motion [59] is granted to the extent that the briefing schedule is stayed. The movants are directed to inform this court within 14 days of the district court's action on the motion, or within 60 days of this order, whichever is sooner, concerning how these appeals should proceed. Service: 01/11/2019 by clerk. [577770] [LMS] [Entered: 01/11/2019 03:49 PM] (2) |
| Jan 10, 2019 | 60 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: motion to stay appeal Docket No. [59], ERROR: The caption listed on the motion does not follow official caption provided by the clerk. CORRECTION: For future filings requiring the official caption, please ensure the caption is correct. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [577190] [JAL] [Entered: 01/10/2019 08:42 AM] (0) |
| Jan 9, 2019 | 59 | MOTION of Appellant Amgen Inc. and Appellees Watson Laboratories, Inc. and Actavis Pharma, Inc. to stay appeal [Consent: unopposed]. Service: 01/09/2019 by email. [577151] [18-2414] [Joshua Fougere] [Entered: 01/09/2019 08:06 PM] (7) |
| Dec 27, 2018 | 58 | ORDER filed. The motion [53] is granted. Service: 12/27/2018 by clerk. [574829] [NL] [Entered: 12/27/2018 04:21 PM] (2) |
| Dec 18, 2018 | 57 | ORDER filed. The motion [56] is granted to the extent that all appellees’ response briefs and all cross-appellants’ opening-and-response briefs are due no later than February 8, 2019. Service: 12/18/2018 by clerk. [572639] [NL] [Entered: 12/18/2018 12:04 PM] (2) |
| Dec 12, 2018 | 56 | MOTION of Appellees Watson Laboratories, Inc., Actavis Pharma, Inc. and Cross-Appellants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd. to extend the time to 02/08/2019 to file the Deadline to file Appellees' and Cross-Appellants' briefs. [Consent: partial consent]. Service: 12/12/2018 by email. [571447] [18-2414] [Steffen Johnson] [Entered: 12/12/2018 09:47 PM] (11) |
| Dec 11, 2018 | 52 | Entry of appearance for Renita S. Rathinam as of counsel for Cross-Appellants Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc.. Service: 12/11/2018 by email. [571038] [18-2414] [Steven Maddox] [Entered: 12/11/2018 05:12 PM] (2) |
| Dec 11, 2018 | 53 | MOTION of Appellant Amgen Inc. to waive confidentiality requirements [Consent: unopposed]. Service: 12/11/2018 by email. [571060] [18-2414] [Bradford Badke] [Entered: 12/11/2018 06:27 PM] (39) |
| Dec 11, 2018 | 54 | MODIFIED ENTRY: CORRECTED BRIEF FILED for Appellant Amgen Inc. Number of Pages: 64. Service: 12/11/2018 by email. [571063]--[Edited 01/07/2019 by MJL - brief accepted by order [58]] [Bradford Badke] [Entered: 12/11/2018 06:29 PM] (168) |
| Dec 11, 2018 | 55 | MODIFIED ENTRY: CORRECTED CONFIDENTIAL BRIEF FILED for Appellant Amgen Inc. Number of Pages: 64. Service: 12/11/2018 by email. [571064]--[Edited 01/07/2019 by MJL - brief accepted by order [58]] [Bradford Badke] [Entered: 12/11/2018 06:30 PM] (0) |
| Dec 10, 2018 | 51 | NOTICE OF NON-COMPLIANCE: The submissions of Appellant Amgen Inc., Opening Brief (confidential [48], nonconfidential [49]) and Motion [50], are not in compliance with the rules of this court (see attached). Compliant brief and motion due 12/17/2018. Service as of this date by the Clerk of Court. [570382] [MJL] [Entered: 12/10/2018 08:55 AM] (3) |
| Nov 30, 2018 | 48 | TENDERED from Appellant Amgen Inc.. Title: CONFIDENTIAL COMBINED OPENING BRIEF & APX (per FCR 30(d)). Service: 11/30/2018 by email. [569068] [18-2414]. This brief is non-compliant. See Doc. No. [51]. [Bradford Badke] [Entered: 11/30/2018 07:10 PM] (0) |
| Nov 30, 2018 | 49 | TENDERED from Appellant Amgen Inc.. Title: COMBINED OPENING BRIEF & APX (per FCR 30(d)). Service: 11/30/2018 by email. [569070] [18-2414]. This brief is non-compliant. See Doc. No. [51]. [Bradford Badke] [Entered: 11/30/2018 07:12 PM] (167) |
| Nov 30, 2018 | 50 | MOTION of Appellant Amgen Inc. to seal document confidential Brief [48] [Consent: not addressed]. Service: 11/30/2018 by email. [569071] [18-2414]. This motion is non-compliant. See Doc. No. [51]. [Bradford Badke] [Entered: 11/30/2018 07:14 PM] (36) |
| Oct 24, 2018 | 46 | ORDER consolidating appeals 18-2414 and19-1086. The appellants opening brief is due no later than 60 days from the date of filing of this order. Service as of this date by the Clerk of Court. [559963] [18-2414, 19-1086] [CAB] [Entered: 10/24/2018 11:13 AM] (2) |
| Oct 24, 2018 | 47 | Note to file: The following cases are associated:18-2414 Lead with 19-1086 Cross-Appeal. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [559975] [18-2414, 19-1086] [CAB] [Entered: 10/24/2018 11:30 AM] (0) |
| Oct 23, 2018 | 45 | Entry of appearance for Lauren Cranford Katzeff as of counsel for Appellant Amgen Inc.. Service: 10/23/2018 by email. [559806] [18-2414] [Bradford Badke] [Entered: 10/23/2018 09:07 PM] (2) |
| Oct 16, 2018 | 43 | Corrected Certificate of Interest for the Appellees Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.. Service: 10/16/2018 by email. [557623] [18-2414] [Steven Maddox] [Entered: 10/16/2018 01:59 PM] (3) |
| Oct 16, 2018 | 44 | Entry of appearance for Christopher B. Essig as of counsel for Appellees Actavis Pharma, Inc. and Watson Laboratories, Inc.. Service: 10/16/2018 by email. [557814] [18-2414] [Christopher Essig] [Entered: 10/16/2018 04:26 PM] (2) |
| Oct 15, 2018 | 42 | Corrected Certificate of Interest for the Appellees Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.. Service: 10/15/2018 by email. [557267] [18-2414] [Steven Maddox] [Entered: 10/15/2018 04:59 PM] (3) |
| Oct 12, 2018 | 36 | Entry of appearance for Steven A. Maddox as principal counsel for Appellees Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.. Service: 10/12/2018 by email. [556713] [18-2414] [Steven Maddox] [Entered: 10/12/2018 01:46 PM] (2) |
| Oct 12, 2018 | 37 | Entry of appearance for Jeremy J. Edwards as of counsel for Appellees Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc.. Service: 10/12/2018 by email. [556719] [18-2414] [Steven Maddox] [Entered: 10/12/2018 01:52 PM] (2) |
| Oct 12, 2018 | 38 | Entry of appearance for Matthew C. Ruedy as of counsel for Appellees Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.. Service: 10/12/2018 by email. [556725] [18-2414] [Steven Maddox] [Entered: 10/12/2018 01:58 PM] (2) |
| Oct 12, 2018 | 39 | Entry of appearance for Kaveh Saba as of counsel for Appellees Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc.. Service: 10/12/2018 by email. [556726] [18-2414] [Steven Maddox] [Entered: 10/12/2018 02:00 PM] (2) |
| Oct 12, 2018 | 40 | Corrected Entry of appearance for Christopher Casieri as of counsel for Appellees Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc.. Service: 10/12/2018 by email. [556727] [18-2414] [Steven Maddox] [Entered: 10/12/2018 02:02 PM] (2) |
| Oct 12, 2018 | 41 | Docketing Statement for the Appellees Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.. Service: 10/12/2018 by email. [556728] [18-2414] [Steven Maddox] [Entered: 10/12/2018 02:07 PM] (4) |
| Oct 10, 2018 | 30 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [4], ERROR: Counsel has not updated his firm's address information in CM/ECF. CORRECTION: Counsel should promptly update his firm address in CM/ECF to match the address listed on his entry of appearance. [555867] [MMA] [Entered: 10/10/2018 09:16 AM] (0) |
| Oct 10, 2018 | 31 | NOTICE OF NON-COMPLIANCE: The submission of Appellees Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc., Certificate of Interest and Entry of Appearance - Zydus Pharmaceuticals and Cadila Healthcare Ltd. [8], is not in compliance with the rules of this court (see attached). Compliant documents due on 10/17/2018. Service as of this date by the Clerk of Court.[555898] [MMA] [Entered: 10/10/2018 09:43 AM] (2) |
| Oct 10, 2018 | 32 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Amgen Inc., Entry of Appearance - Appellant [23], is not in compliance with the rules of this court (see attached). Compliant document due on 10/17/2018. Service as of this date by the Clerk of Court.[555956] [MMA] [Entered: 10/10/2018 11:08 AM] (1) |
| Oct 10, 2018 | 33 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [28], ERROR: Attorney Joshua I. Rothman is not a registered CM/ECF filer with the Federal Circuit. CORRECTION: Pursuant to FCR 25(a)(2), attorneys who appear before this court must register for the court's CM/ECF system. Please register promptly. [555965] [MMA] [Entered: 10/10/2018 11:21 AM] (0) |
| Oct 10, 2018 | 34 | Entry of appearance for Ryan C. Morris as of counsel for Appellant Amgen Inc.. Service: 10/10/2018 by email. [555999] [18-2414] [Ryan Morris] [Entered: 10/10/2018 12:18 PM] (2) |
| Oct 10, 2018 | 35 | Official caption revised to correct Appellee Piramal Healthcare UK Limited's name. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by the Clerk of Court. [556108] [CAB] [Entered: 10/10/2018 03:12 PM] (0) |
| Oct 9, 2018 | 2 | Entry of appearance for Brenda L. Joly as of counsel for Appellees Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals of New York LLC. Service: 10/09/2018 by email. [555608] [18-2414] [Brenda Joly] [Entered: 10/09/2018 01:11 PM] (2) |
| Oct 9, 2018 | 3 | Entry of appearance for Jacob M. Holdreith as principal counsel for Appellees Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals of New York LLC. Service: 10/09/2018 by email. [555609] [18-2414] [Brenda Joly] [Entered: 10/09/2018 01:13 PM] (2) |
| Oct 9, 2018 | 4 | Entry of appearance for Oren D. Langer as of counsel for Appellees Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals of New York LLC. Service: 10/09/2018 by email. [555610] [18-2414] [Brenda Joly] [Entered: 10/09/2018 01:15 PM] (2) |
| Oct 9, 2018 | 5 | Entry of appearance for Kelsey J. Thorkelson as of counsel for Appellees Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals of New York LLC. Service: 10/09/2018 by email. [555612] [18-2414] [Brenda Joly] [Entered: 10/09/2018 01:17 PM] (2) |
| Oct 9, 2018 | 6 | Certificate of Interest for the Appellees Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals of New York LLC. Service: 10/09/2018 by email. [555613] [18-2414] [Brenda Joly] [Entered: 10/09/2018 01:18 PM] (3) |
| Oct 9, 2018 | 7 | Docketing Statement for the Appellees Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals of New York LLC. Service: 10/09/2018 by email. [555615] [18-2414] [Brenda Joly] [Entered: 10/09/2018 01:20 PM] (3) |
| Oct 9, 2018 | 8 | Certificate of Interest for the Appellee Zydus Pharmaceuticals (USA) Inc. Service: 10/09/2018 by email. [555647] [18-2414]. These documents are non-compiant. See Doc. No.[31] [William Hare] [Entered: 10/09/2018 02:34 PM] (3) |
| Oct 9, 2018 | 9 | Entry of appearance for Zachary L. Sorman as of counsel for Appellees Actavis Pharma, Inc. and Watson Laboratories, Inc.. Service: 10/09/2018 by email. [555780] [18-2414] [Zachary Sorman] [Entered: 10/09/2018 05:00 PM] (2) |
| Oct 9, 2018 | 10 | Docketing Statement for the Appellees Actavis Pharma, Inc. and Watson Laboratories, Inc.. Service: 10/09/2018 by email. [555781] [18-2414] [Zachary Sorman] [Entered: 10/09/2018 05:04 PM] (5) |
| Oct 9, 2018 | 11 | Certificate of Interest for the Appellees Actavis Pharma, Inc. and Watson Laboratories, Inc.. Service: 10/09/2018 by email. [555783] [18-2414] [Zachary Sorman] [Entered: 10/09/2018 05:07 PM] (4) |
| Oct 9, 2018 | 12 | Entry of appearance for George C. Lombardi as principal counsel for Appellees Actavis Pharma, Inc. and Watson Laboratories, Inc.. Service: 10/09/2018 by email. [555784] [18-2414] [George Lombardi] [Entered: 10/09/2018 05:09 PM] (2) |
| Oct 9, 2018 | 13 | Entry of appearance for Steffen N. Johnson as of counsel for Appellees Actavis Pharma, Inc. and Watson Laboratories, Inc.. Service: 10/09/2018 by email. [555785] [18-2414] [Steffen Johnson] [Entered: 10/09/2018 05:11 PM] (2) |
| Oct 9, 2018 | 14 | Entry of appearance for Bradford J. Badke as principal counsel for Appellant Amgen Inc.. Service: 10/09/2018 by email. [555795] [18-2414] [Bradford Badke] [Entered: 10/09/2018 05:58 PM] (2) |
| Oct 9, 2018 | 15 | Docketing Statement for the Appellant Amgen Inc.. Service: 10/09/2018 by email. [555796] [18-2414] [Bradford Badke] [Entered: 10/09/2018 06:01 PM] (4) |
| Oct 9, 2018 | 16 | Certificate of Interest for the Appellant Amgen Inc.. Service: 10/09/2018 by email. [555798] [18-2414] [Bradford Badke] [Entered: 10/09/2018 06:03 PM] (3) |
| Oct 9, 2018 | 17 | Entry of appearance for Aaron F. Barkoff as principal counsel for Piramal Healthcare UK Limited. Service: 10/09/2018 by email. [555799] [18-2414] [Aaron Barkoff] [Entered: 10/09/2018 06:11 PM] (2) |
| Oct 9, 2018 | 18 | Certificate of Interest for the Appellee Piramal Healthcare UK Limited. Service: 10/09/2018 by email. [555800] [18-2414]--[Edited 10/10/2018 by CAB to correct party filer's name] [Aaron Barkoff] [Entered: 10/09/2018 06:20 PM] (3) |
| Oct 9, 2018 | 19 | Docketing Statement for the Appellee Piramal Healthcare UK Limited. Service: 10/09/2018 by email. [555802] [18-2414] --[Edited 10/10/2018 by CAB to correct party filer's name] [Aaron Barkoff] [Entered: 10/09/2018 06:22 PM] (4) |
| Oct 9, 2018 | 20 | Entry of appearance for Alejandro Menchaca as of counsel for Piramal Healthcare UK Limited. Service: 10/09/2018 by email. [555803] [18-2414] [Alejandro Menchaca] [Entered: 10/09/2018 06:26 PM] (2) |
| Oct 9, 2018 | 21 | Entry of appearance for Sona De as of counsel for Appellant Amgen Inc.. Service: 10/09/2018 by email. [555804] [18-2414] [Sona De] [Entered: 10/09/2018 06:43 PM] (2) |
| Oct 9, 2018 | 22 | Entry of appearance for Joshua J. Fougere as of counsel for Appellant Amgen Inc.. Service: 10/09/2018 by email. [555805] [18-2414] [Joshua Fougere] [Entered: 10/09/2018 06:47 PM] (2) |
| Oct 9, 2018 | 23 | Entry of appearance for Ryan C. Morris as of counsel for Appellant Amgen Inc. Service: 10/09/2018 by email. [555806] [18-2414]. This document is non-compliant. See Doc. No.[32] [Ryan Morris] [Entered: 10/09/2018 06:52 PM] (2) |
| Oct 9, 2018 | 24 | Entry of appearance for Eric M. Agovino as of counsel for Appellant Amgen Inc.. Service: 10/09/2018 by email. [555808] [18-2414] [Bradford Badke] [Entered: 10/09/2018 07:04 PM] (2) |
| Oct 9, 2018 | 25 | Entry of appearance for Lois M. Kwasigroch as of counsel for Appellant Amgen Inc.. Service: 10/09/2018 by email. [555809] [18-2414] [Bradford Badke] [Entered: 10/09/2018 07:06 PM] (2) |
| Oct 9, 2018 | 26 | Entry of appearance for Wendy A. Whiteford as of counsel for Appellant Amgen Inc.. Service: 10/09/2018 by email. [555810] [18-2414] [Bradford Badke] [Entered: 10/09/2018 07:09 PM] (2) |
| Oct 9, 2018 | 27 | Entry of appearance for John D. Murnane as of counsel for Appellant Amgen Inc.. Service: 10/09/2018 by email. [555812] [18-2414] [Bradford Badke] [Entered: 10/09/2018 07:11 PM] (2) |
| Oct 9, 2018 | 28 | Entry of appearance for Joshua I. Rothman as of counsel for Appellant Amgen Inc.. Service: 10/09/2018 by email. [555814] [18-2414] [Bradford Badke] [Entered: 10/09/2018 07:14 PM] (2) |
| Oct 9, 2018 | 29 | Entry of appearance for Alicia A. Russo as of counsel for Appellant Amgen Inc.. Service: 10/09/2018 by email. [555816] [18-2414] [Bradford Badke] [Entered: 10/09/2018 07:15 PM] (2) |
| Sep 25, 2018 | 1 | Appeal docketed. Received: 09/21/2018. [552293]Entry of Appearance due 10/09/2018. Certificate of Interest due 10/09/2018. Docketing Statement due 10/09/2018. Appellant's brief due 11/26/2018. [MJL] [Entered: 09/25/2018 09:56 AM] (55) |
